메뉴 건너뛰기




Volumn 25, Issue 7, 2015, Pages 1621-1626

Minimization of drug-drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators

Author keywords

Alzheimers disease; Amyloid beta; Cytochrome P450 3A4; Drugdrug interactions; Gamma secretase modulator; Natural product; Semisynthesis; Sterol

Indexed keywords

APPARENT LIFE THREATENING EVENT; ARTICLE; BLEEDING; CATHETER COMPLICATION; CATHETER DISLODGEMENT; CATHETER INFECTION; CATHETER MIGRATION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; DEVICE SAFETY; HUMAN; SUTURE; TECHNOLOGY; THERAPY DELAY; VASCULAR ACCESS; VEIN INJURY; VEIN THROMBOSIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DOSE RESPONSE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION;

EID: 84925057498     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.01.051     Document Type: Article
Times cited : (8)

References (11)
  • 11
    • 84925207592 scopus 로고    scopus 로고
    • The development of SPI-1865 was halted
    • The development of SPI-1865 was halted.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.